H. Shin et al., THROMBIN RECEPTOR-MEDIATED SYNOVIAL PROLIFERATION IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Clinical immunology and immunopathology, 76(3), 1995, pp. 225-233
Synovial cell proliferation is one of the pathological bases of rheuma
toid arthritis (RA). Several cytokines including IL-1 and IL-6 and gro
wth factors have been shown to be involved in the synovial cell prolif
eration in RA, Thrombin is a multifunctional protease and acts as a mi
togen for several cell types through its specific receptor. To assess
whether thrombin is involved in overproliferation of rheumatoid synovi
al cells, we measured the concentration of thrombin-antithrombin III (
ATIII) complex (TAT) in synovial fluid obtained from patients with RA
or osteoarthritis (OA). We also examined the effect of thrombin or thr
ombin receptor agonist peptide (TRAP) on cell growth of synovial cell
clones (SCCs) established from an RA patient. The concentrations of TA
T in the synovial fluid from patients with RA were significantly highe
r than in those with OA. Moreover, both thrombin and TRAP enhanced pro
liferation of synovial cells in vitro. We also characterized the expre
ssion of thrombin receptor mRNA by reverse transcription-PCR. The expr
ession of mRNA for thrombin receptor was up-regulated by thrombin or T
RAP stimulation. Thrombin receptor antigen was also detected on both S
CCs and synovial tissue from RA patients by immunostaining using a mon
oclonal antibody against thrombin receptor. These findings indicate th
at thrombin may act as a mitogen for synovial cells through thrombin r
eceptor and may play some role in synovial overproliferation and remod
eling in RA. (C) 1995 Academic Press, Inc.